Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue SUPPL. 2, 1999, Pages 41-45

  Denninger, Marie Hélène ^a   Necciari, José ^b   Serre Lacroix, Evelyne ^b   Sissmann, Joëlle ^b  

^a BEAUJON HOSPITAL   (France)

^b SANOFI   (France)

Author keywords

Atherosclerotic patients; Bleeding time; Elderly subjects; Pharmacokinetics; Platelet aggregation; Young subjects

Indexed keywords

2 (2 CHLOROPHENYL) 2 (4,5,6,7 TETRAHYDROTHIENO[3,2 C]PYRIDIN 5 YL)ACETIC ACID; CLOPIDOGREL; DRUG METABOLITE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; BLEEDING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ARTERIOSCLEROSIS; BLEEDING TIME; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0032801029     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Born GVR, Cross J. The aggregation of blood platelets. J Physiol 1963;168:178-95
2. Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous "venostasis" bleeding time technique. J Lab Clin Med 1941;26:1812-1822
3. Herbert JM, Frehel D, Vallee E, et al. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993;11:180-198
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;15:31-41
5. 14C-labelled clopidogrel. Semin Thromb Hemost 1999;25(Suppl 2):29-34
6. Savi P, Combalbert J, Gaich C, et al. The antiaggregating activity of clopidogrel is due to a metabolic activation by hepatic cytochrome P450-1A. Thromb Haemost 1994;72:313-317
7. Lowe GDO, Rumley A, Griffiths P, et al. Dose-dependent inhibition of platelet aggregation in healthy volunteers by a new agent, SR25990C. Thromb Haemost 1989;62:414(Abst)
8. th Congress of the International Society on Thrombosis and Hemostasis, Tokyo, Japan, 19-25 August 1989. Thromb Haemost 1989;62:410(Abst)
9. Thebault JJ, Kieffer G, Lowe GDO, Nimmo WS, Cariou R. Repeated-dose pharmacodynamics of clopidogrel in Healthy Subjects. Semin Thromb Hemost 1999;25(Suppl 2):9-14